Communications
functional groups. The dissymmetric spirolactone 4 was
manner, reminiscent of a reaction developed by Wardrop
et al. for the production of spiroamides from nitrenes.[10] To
our delight, sequential exposure of the acid 5 to hypervalent
iodine and DBN provided the spirocyclic lactone 4 as the
major diastereomer (61% overall yield, > 12:1 d.r.); this
outcome was confirmed by nOe examination of the chroma-
tographically separable isomers.[11]
To capitalize upon the directing effect of the tertiary
alcohol,[12] we next exposed the dienone 4 to pyrrolidine.
Without purification, the corresponding enone-amide partici-
pated in sequential nucleophilic epoxidation (tert-butyl
hydroperoxide, DBN) and afforded a syn-epoxide (62%
yield, single diastereomer, see the Supporting Information).
Relactonization proceeded upon the addition of acetic acid
and furnished the spirolactone 13 (92% yield).
Having successfully established four of the stereocenters,
we imagined that stereoselective reduction of the carbonyl
residues and rearrangement should complete the synthesis of
isariotin E (3) from the vinylogous ester 13. The necessary
diastereocontrol required to prevent an undesired Payne
rearrangement required a two-step reduction protocol. The
vinylogous ester 13 undergoes reduction with sodium boro-
hydride to afford the corresponding syn-epoxy alcohol, which
underwent additional reduction as a crude reaction mixture
using Dibal-H to arrive at a hemiketal; a compound that we
have tentatively assigned as the lactol 14 (56% overall yield,
one diastereomer). Treatment of this allylic alcohol function-
ality with trichloroacetic acid (1:10 H2O/CH2Cl2) resulted in
isariotin E (3) in 74% yield. The NMR data for the synthetic
compound 3 matched those of isariotin E in every respect,
concluding the first total synthesis for 3.
envisioned to serve as a key platform, whose fixed geometry
might enable smooth exchange of amine functionality. It
could arise from an ipso dearomatization of the unnatural
amino acid 5, a resorcinol surrogate of tyrosine, which we
suspected could be procured through a Horner–Wadsworth–
Emmons olefination with the commercially available benzal-
dehyde 6, and subsequent reduction. With regards to the
selection of the starting amine protecting group (R’), our
decision to capitalize upon the amino acid construction
method of Schmidt et al.,[6] and the customary questions of
functional group compatibility constrained our choices to
carbamates.
Our route therefore began with O-Boc protection of the
commercially available phenol 6 (Scheme 2). We found that
in the presence of 1,1,3,3-tetramethyl guanidine (TMG), the
differentially protected benzaldehyde 7 can be elaborated
with N-Boc-protected phosphonate 8,[7] prepared using the
protocol of Schmidt et al., to afford the vinyl carbamate 9
(78% yield, E/Z 1:9, > 10 g scale). For our purposes, both of
these olefinic isomers proceeded to compound 10 upon
hydrogenation (Pd/C, H2), and therefore improvement of this
ratio necessitated no further attention. Global removal of
-NBoc and -OBoc residues in compound 10 (5:1 CH2Cl2/
TFA) afforded the corresponding ammonium salt, which
subsequently underwent selective amide bond formation with
the acid 11 to produce the amide 12 (82% yield). Additional
hydrolysis of the methyl ester 12 with lithium hydroxide
afforded compound 5 (88% yield). With the desired monop-
rotected resorcinol tyrosine analogue in hand, we were poised
to test the oxidative dearomatization of the dissymmetric
resorcinol.[8,9] We hoped that the methoxy and amine residues
would emerge being positioned on opposite sides of the
With ample quantities of the hemiketal 3 in hand, we were
positioned to test the putative skeletal rearrangements
(Scheme 3). Initially, we suspected that both isariotin F (2)
conjoined spirocyclic molecule in
a diastereoselective
Scheme 2. Synthesis of isariotin E (3). Reagents and conditions: a) Boc2O (1.5 equiv), NEt3 (3.0 equiv), DMAP (0.1 equiv), CH2Cl2, RT, 12 h,
>95%; b) 7 (1.3 equiv), TMG (1.5 equiv), THF, RT, 18 h, 78%; c) Pd/C (0.04 equiv), H2, EtOAc/MeOH (1:1), RT, 12 h, >95%; d) TFA/CH2Cl2
(1:5), RT, 24 h, concentrate; then 13 (1.3 equiv), EDCI (1.3 equiv), NEt3 (5.0 equiv), DMF, RT, 16 h, 82%; e) LiOH·H2O (3.0 equiv), THF/MeOH/
H2O (1:1:1), RT, 20 h, 88%; f) PhI(OAc)2 (1.5 equiv), TFA (2.3 equiv), CH2Cl2, 08C!RT, 3 h; g) DBN (0.5 equiv), CH2Cl2, RT, 2 h, 61% over two
steps, >12:1 d.r.; h) pyrrolidine (1.5 equiv), CH2Cl2, RT, 14 h, concentrate; then tBuOOH (10 equiv), DBN (10 equiv), CH2Cl2, RT, 6 h, 62%;
i) AcOH (5 equiv), CH2Cl2, reflux, 8 h, 92%; j) NaBH4 (3.0 equiv), THF/H2O (10:1), 08C, 30 min; k) Dibal-H (4.5 equiv), CH2Cl2, ꢀ788C, 10 min,
56% over 2 steps; l) Cl3CCO2H (11 equiv), CH2Cl2/H2O (10:1), RT, 6 h, 74%. Boc=tert-butoxycarbonyl, DMAP=4-dimethylaminopyridine,
TMG=1,1,3,3,-tetramethylguanidine, THF=tetrahydrofuran, TFA=trifluoroacetic acid, EDCI=1-ethyl-3-(3-dimethylaminopropyl) carbodiimide
hydrochloride, DMF=N,N-dimethylformamide, DBN=1,5-diazabicyclo[4.3.0]non-5-ene, Dibal-H=diisobutylaluminum hydride.
ꢀ 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Angew. Chem. Int. Ed. 2009, 48, 9519 –9521